Skip to Content

Tildrakizumab-asmn

Pronunciation

(til dra KIZ eu mab asmn)

Index Terms

  • Ilumya

Pharmacologic Category

  • Antipsoriatic Agent
  • Interleukin-23 Inhibitor
  • Monoclonal Antibody

Use: Labeled Indications

Plaque psoriasis: Treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Contraindications

Serious hypersensitivity to tildrakizumab or any component of the formulation

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide